Richard Robert E. 4
4 · Lyra Therapeutics, Inc. · Filed Feb 2, 2023
Insider Transaction Report
Form 4
Richard Robert E.
SVP of R&D
Transactions
- Award
Common Stock
2023-01-31+30,000→ 30,000 total - Award
Stock Option
2023-01-31+45,000→ 45,000 totalExercise: $2.85Exp: 2033-01-30→ Common Stock (45,000 underlying)
Footnotes (2)
- [F1]Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in four (4) equal annual installments on the first four anniversaries of the grant date such that the RSUs will fully vest on January 31, 2027.
- [F2]This option vests and becomes exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following January 31, 2023.